LISATA THERAPEUTICS INC (LSTA) Stock Analyst Earnings Estimates
NASDAQ:LSTA - Nasdaq - US1280583022 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1M | -100.00% | 5.1M | 3.672M -28.00% | 46.92M 1,177.78% | 132.6M 182.61% | 249.9M 88.46% | ||||
| EBITDA YoY % growth | -57.53M -98.45% | -25.519M 55.64% | -22.235M 12.87% | -27.438M -23.40% | -31.518M -14.87% | -36.312M -15.21% | -31.416M 13.48% | N/A | N/A | N/A | |
| EBIT YoY % growth | -57.6M -98.28% | -25.708M 55.37% | -22.409M 12.83% | -25.538M -13.96% | -40.8M -59.76% | -34.17M 16.25% | -46.308M -35.52% | -43.86M 5.29% | -29.58M 32.56% | 111.18M 475.86% | |
| Operating Margin | N/A | N/A | -2,240.90% | N/A | N/A | -670.00% | -1,261.11% | -93.48% | -22.31% | 44.49% | |
| EPS YoY % growth | -11.34 -45.38% | -2.58 77.25% | -2.40 6.98% | -2.56 -6.82% | -1.13 56.03% | -1.01 9.95% | -1.19 -17.59% | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.68 -14.97% | -0.77 -40.02% |
| Revenue Q2Q % growth | -100.00% | |
| EBITDA Q2Q % growth | -6.528M -25.47% | -7.14M -49.53% |
| EBIT Q2Q % growth | -6.222M -16.60% | -6.844M -38.29% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.54 11.48% | -0.66 | 0.12 | 18.55% |
| Q1 2025 Q2Q % growth | -0.55 15.38% | -0.54 | -0.01 | -1.74% |
| Q4 2024 Q2Q % growth | -0.55 16.67% | -0.78 | 0.23 | 29.05% |
| Q3 2024 Q2Q % growth | -0.59 9.23% | -0.77 | 0.18 | 22.88% |
| Q2 2024 Q2Q % growth | -0.61 -22.00% | -0.78 | 0.17 | 21.31% |
| Q1 2024 Q2Q % growth | -0.65 15.58% | -0.74 | 0.09 | 12.10% |
| Q4 2023 Q2Q % growth | -0.66 13.16% | -0.91 | 0.25 | 27.30% |
| Q3 2023 Q2Q % growth | -0.65 91.75% | -0.95 | 0.30 | 31.48% |
| Q2 2023 Q2Q % growth | -0.50 69.70% | -0.71 | 0.21 | 29.97% |
| Q1 2023 Q2Q % growth | -0.77 26.67% | -0.83 | 0.06 | 6.80% |
| Q4 2022 Q2Q % growth | -0.76 53.94% | -1.03 | 0.27 | 26.23% |
| Q3 2022 Q2Q % growth | -7.88 -337.78% | -0.92 | -6.96 | -758.39% |
| Q2 2022 Q2Q % growth | -1.65 -10.00% | -1.48 | -0.17 | -11.56% |
| Q1 2022 Q2Q % growth | -1.05 63.16% | -1.48 | 0.43 | 29.01% |
| Q4 2021 Q2Q % growth | -1.65 60.71% | -2.22 | 0.57 | 25.63% |
| Q3 2021 Q2Q % growth | -1.80 58.62% | -2.30 | 0.49 | 21.57% |
| Q2 2021 Q2Q % growth | -1.50 -120.00% | -2.22 | 0.72 | 32.39% |
| Q1 2021 Q2Q % growth | -2.85 50.00% | -1.30 | -1.55 | -119.15% |
| Q4 2020 Q2Q % growth | -4.20 40.43% | -3.88 | -0.32 | -8.36% |
| Q3 2020 Q2Q % growth | -4.35 38.30% | -4.44 | 0.09 | 1.96% |
| Q2 2020 Q2Q % growth | 7.50 202.04% | -5.93 | 13.43 | 226.50% |
| Q1 2020 Q2Q % growth | -5.70 13.64% | -4.44 | -1.26 | -28.47% |
| Q4 2019 Q2Q % growth | -7.05 | -5.28 | -1.77 | -33.56% |
| Q3 2019 Q2Q % growth | -7.05 | -6.58 | -0.47 | -7.16% |
| Q2 2019 Q2Q % growth | -7.35 | -6.81 | -0.54 | -7.95% |
| Q1 2019 Q2Q % growth | -6.60 | -6.50 | -0.10 | -1.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2021 Q2Q % growth | 467.843K | -467.843K | -100.00% | |
| Q1 2021 Q2Q % growth | 672.18K | -672.18K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -5.82% | -14.94% |
| Revenue | N/A | N/A | N/A | N/A |